These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 24962990)
1. Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding. Agyeman A; Jha BK; Mazumdar T; Houghton JA Oncotarget; 2014 Jun; 5(12):4492-503. PubMed ID: 24962990 [TBL] [Abstract][Full Text] [Related]
2. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer. Mazumdar T; DeVecchio J; Agyeman A; Shi T; Houghton JA Oncotarget; 2011 Aug; 2(8):638-45. PubMed ID: 21860067 [TBL] [Abstract][Full Text] [Related]
3. Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells. Mazumdar T; Devecchio J; Agyeman A; Shi T; Houghton JA Cancer Res; 2011 Sep; 71(17):5904-14. PubMed ID: 21747117 [TBL] [Abstract][Full Text] [Related]
4. Regulation of DNA damage following termination of Hedgehog (HH) survival signaling at the level of the GLI genes in human colon cancer. Agyeman A; Mazumdar T; Houghton JA Oncotarget; 2012 Aug; 3(8):854-68. PubMed ID: 23097684 [TBL] [Abstract][Full Text] [Related]
5. Hedgehog signaling drives cellular survival in human colon carcinoma cells. Mazumdar T; DeVecchio J; Shi T; Jones J; Agyeman A; Houghton JA Cancer Res; 2011 Feb; 71(3):1092-102. PubMed ID: 21135115 [TBL] [Abstract][Full Text] [Related]
6. Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing. Zhang R; Wu J; Ferrandon S; Glowacki KJ; Houghton JA Oncotarget; 2016 Dec; 7(49):80190-80207. PubMed ID: 27863397 [TBL] [Abstract][Full Text] [Related]
7. Hedgehog signaling regulates telomerase reverse transcriptase in human cancer cells. Mazumdar T; Sandhu R; Qadan M; DeVecchio J; Magloire V; Agyeman A; Li B; Houghton JA PLoS One; 2013; 8(9):e75253. PubMed ID: 24086482 [TBL] [Abstract][Full Text] [Related]
8. Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy. Réda J; Vachtenheim J; Vlčková K; Horák P; Vachtenheim J; Ondrušová L Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201866 [TBL] [Abstract][Full Text] [Related]
9. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo. Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014 [TBL] [Abstract][Full Text] [Related]
10. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro. You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913 [TBL] [Abstract][Full Text] [Related]
11. Identification of Novel GANT61 Analogs with Activity in Hedgehog Functional Assays and GLI1-Dependent Cancer Cells. Abu Rabe D; Chdid L; Lamson DR; Laudeman CP; Tarpley M; Elsayed N; Smith GR; Zheng W; Dixon MS; Williams KP Molecules; 2024 Jun; 29(13):. PubMed ID: 38999049 [TBL] [Abstract][Full Text] [Related]
12. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer. Huang L; Walter V; Hayes DN; Onaitis M Clin Cancer Res; 2014 Mar; 20(6):1566-75. PubMed ID: 24423612 [TBL] [Abstract][Full Text] [Related]
14. Hedgehog Signal Inhibitor GANT61 Inhibits the Malignant Behavior of Undifferentiated Hepatocellular Carcinoma Cells by Targeting Non-Canonical GLI Signaling. Harada K; Ohashi R; Naito K; Kanki K Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354204 [TBL] [Abstract][Full Text] [Related]
15. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors. Arnhold V; Boos J; Lanvers-Kaminsky C Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311 [TBL] [Abstract][Full Text] [Related]
16. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma. Yan M; Wang L; Zuo H; Zhang Z; Chen W; Mao L; Zhang P Oral Oncol; 2011 Jun; 47(6):504-9. PubMed ID: 21536478 [TBL] [Abstract][Full Text] [Related]
17. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis. Lin Z; Li S; Sheng H; Cai M; Ma LY; Hu L; Xu S; Yu LS; Zhang N J Cancer Res Clin Oncol; 2016 Dec; 142(12):2469-2478. PubMed ID: 27601167 [TBL] [Abstract][Full Text] [Related]
18. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells. Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905 [TBL] [Abstract][Full Text] [Related]
19. Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth. Maresca L; Crivaro E; Migliorini F; Anichini G; Giammona A; Pepe S; Poggialini F; Vagaggini C; Giannini G; Sestini S; Borgognoni L; Lapucci A; Dreassi E; Taddei M; Manetti F; Petricci E; Stecca B Pharmacol Res; 2023 Sep; 195():106858. PubMed ID: 37473878 [TBL] [Abstract][Full Text] [Related]
20. GLI3-dependent transcriptional repression of Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis. Hu MC; Mo R; Bhella S; Wilson CW; Chuang PT; Hui CC; Rosenblum ND Development; 2006 Feb; 133(3):569-78. PubMed ID: 16396903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]